142 related articles for article (PubMed ID: 6450603)
1. In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
Khare AG; Advani SH; Gangal SG
Br J Cancer; 1981 Jan; 43(1):13-8. PubMed ID: 6450603
[TBL] [Abstract][Full Text] [Related]
2. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
3. Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
Gangal SG; Damle NK; Khare AG; Advani SH
Br J Cancer; 1979 Sep; 40(3):391-6. PubMed ID: 292450
[TBL] [Abstract][Full Text] [Related]
4. In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.
Taylor GM
Br J Cancer; 1981 Feb; 43(2):157-68. PubMed ID: 6451236
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.
Chu EH; Stjernswärd J; Clifford P; Klein G
J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923
[TBL] [Abstract][Full Text] [Related]
6. Response of remission lymphocytes to autochthonous leukaemic myeloblasts.
Taylor GM; Freeman CB; Harris R
Br J Cancer; 1976 May; 33(5):501-11. PubMed ID: 1064430
[TBL] [Abstract][Full Text] [Related]
7. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia.
Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH
Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657
[TBL] [Abstract][Full Text] [Related]
8. The relationship of lytic effects against autologous and allogeneic PHA blasts induced in human mixed lymphocyte cultures.
Porzsolt F; Heimpel H
Immunol Lett; 1984; 8(1):33-8. PubMed ID: 6235182
[TBL] [Abstract][Full Text] [Related]
9. Stimulation and reactivity of leukaemic cells in acute myeloid leukaemia.
Pegrum GD; Evans CA; Middleton VL
Acta Haematol; 1974; 51(3):129-39. PubMed ID: 4281988
[No Abstract] [Full Text] [Related]
10. The role of allogeneic cells in the stimulation of cell-mediated cytotoxicity to leukaemia cells. A family study.
Taylor GM; Bradley BA
Cancer Immunol Immunother; 1983; 15(1):39-46. PubMed ID: 6553506
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory ability of adherent blood cells from patients with chronic myeloid leukaemia on DNA-synthesis in non-adherent leukaemic cells and PHA-stimulated lymphocytes.
Unsgaard G; Lamvik JO
Scand J Haematol; 1980 Aug; 25(2):97-106. PubMed ID: 6936774
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.
Gangal SG; Gothoskar BP; Joshi CS; Advani SH
Br J Cancer; 1976 Mar; 33(3):267-72. PubMed ID: 1063589
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies reactive with human myeloid leukaemia cells.
Ball ED; Fanger MW
Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
[TBL] [Abstract][Full Text] [Related]
14. Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell lines.
Garland JM; Aldridge A; Wagstaffe J; Dexter TM
Br J Cancer; 1983 Aug; 48(2):247-59. PubMed ID: 6411109
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.
Somasundaram R; Rao SG; Advani SH; Gangal SG
Cancer Immunol Immunother; 1988; 27(2):177-82. PubMed ID: 3262014
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects on splenic ultrafiltrates upon leukaemic lymphocytes.
Attallah AM; Houck JC
Br J Cancer; 1975 Dec; 32(6):693-9. PubMed ID: 1062220
[TBL] [Abstract][Full Text] [Related]
17. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
[TBL] [Abstract][Full Text] [Related]
19. In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells.
Kedar E; Raanan Z; Kafka I; Holland JF; Bekesi G; Weiss DW
J Immunol Methods; 1979; 28(3-4):303-19. PubMed ID: 383844
[TBL] [Abstract][Full Text] [Related]
20. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions.
Datta AR; Barrett AJ; Jiang YZ; Guimarães A; Mavroudis DA; van Rhee F; Gordon AA; Madrigal A
Bone Marrow Transplant; 1994 Oct; 14(4):517-24. PubMed ID: 7858526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
